Bioactivity | hCYP1B1-IN-1 (compound B18) is a hCYP1B1 inhibitor (IC50=3.6 nM),as well as an antagonist of Aryl Hydrocarbon Receptor. hCYP1B1-IN-1 exhibtis suitable metabolic stability and good cell-permeability. hCYP1B1-IN-1 inhibits migration of MCF-7 cells[1]. |
Target | IC50: 3.6 nM (hCYP1B1) |
Name | hCYP1B1-IN-1 |
Formula | C18H14ClF3O3 |
Molar Mass | 370.75 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Wu Y, et al. Discovery of 4'-trifluoromethylchalcones as novel, potent and selective hCYP1B1 inhibitors without concomitant AhR activation. Eur J Med Chem. 2023 Oct 5;258:115552. |